Drug
Volulyte
Volulyte: highest development phase Post-Market, developed by Fresenius Kabi. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Fresenius Kabi
Trials
| Drug | Phase | Indication |
|---|---|---|
| Volulyte NCT01689506 | Post-Market | Burns |
Latest
No recent events.
Follow Volulyte on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.